Coronavirus Disease-2019 (COVID-19): An Overview
DOI:
https://doi.org/10.22270/ajprd.v9i1.896Keywords:
2019-nCoV COVID-19 eruption, SARS-CoV-2 Novel coronavirusAbstract
There is a new public health crises threatening the world with the emergence and unfold of two019 novel coronavirus (2019-nCoV) or the severe acute metabolism syndrome coronavirus two (SARS-CoV-2). COVID-19 is a spread of coronavirus is the family Coronaviridae. The malady is believed to originate from crackers Associate in Nursing was unfold to people through unknown medium in an exceedingly town, China. Severe acute metabolism syndrome coronavirus 2 (SARS- CoV-2) could also be a very transmissible and infective coronavirus that emerged in late 2019 and has caused an outbreak|avirus|a virulent disease|a pestilence} of acute disease, named, ‘coronavirus malady 2019’ (COVID-19), that threatens human health and public safety. throughout this Review, we have a tendency to to tend to explain the essential medicine of SARS- CoV-2, together with genomic characteristics, and receptor use, lightness its key distinction from antecedent acquainted coronaviruses. we have a tendency to to tend to summarize current data of clinical, medicine, and pathological choices of COVID-19, additionally as recent progress in animal models, and antiviral treatment approach for SARS- CoV-2 infection. we have a tendency to to tend to to boot discuss the potential life hosts and disease origin of this rising virus well.
Downloads
References
2. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology, 2000; 8:S9–14.
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506.
4. Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91:264–6.
5. Singhal TA Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr, 2020; 87: 281-286.
6. Anjorin AA The coronavirus disease 2019 (COVID-19) pandemic: A review and an update on cases in Africa. Asian Pac J Trop Med, 2020; 13: 199-203.
7. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, et al. COVID-19 and Cardiovascular Disease. Circulation, 2020; 141: 1648-1655.
8. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, et al. Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health, 2020; 13: 667-673.
9. Cheng VCC, Lau SKP, Woo PCY, Yuen KY Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clinical Microbiology Reviews, 2007; 20: 660-694.
10. He F, Deng Y, Li W Coronavirus Disease 2019 (COVID‐19): What we know? Journal of Medical Virology, 2020; 92: 1-12.
11. Brand S, Aziza R, Kombe I, Agoti C, Hilton J, et al. Forecasting the scale of the COVID-19 epidemic in Kenya. MedRxiv.org – the preprint server for Health Sciences, 2020; 1-20.
12. Altmann DM, Douek DC, Boyton RJ What policy makers need to know about COVID-19 protective immunity. Lancet, 2020; 395: 1527-1529.
13. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall R et al. COVID- 19: consider cytokine storm syndromes and immunosuppression. Lancet, 2020; 95: 1033-1034.
14. Padron-Regalado E Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. Infect Dis Ther, 2020; 9: 255-274.
15. Weiss SR, Navas-Martin S Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol MolBiol Rev, 2005; 69: 635-664.
16. Cui, J., Li, F. & Shi, Z. L. Origin and evolutionof pathogenic coronaviruses. Nat. Rev. Microbiol, 2019; 17, 181–192.
17. Wu, J. T., Leung, K. & Leung, G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 2020; 395, 689–697.
18. Hui, D. S. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Intl. J. Infect. Dis, 2020; 91, 264–266.
19. Deng, S. Q. & Peng, H. J. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med, 2020; 9, 575.
20. Han, Q., Lin, Q., Jin, S. & You, L. Coronavirus 2019- nCoV: a brief perspective from the front line. J. Infect,2020; 80, 373–377.
21. Zhu, N. et al. A Novel Coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med, 2020; 382, 727–733.
22. Gralinski, L. E. & Menachery, V. D. Return of the coronavirus: 2019-nCoV. Viruses, 2020; 12, 135.
23. Jiang, S., Du, L. &Shi, Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg. Microbes Infect., 2020; 9, 275–277.
24. Hughes J, Wilson M, Luby S, Gurley E, Hossain M. Transmission of human infec-tion with Nipah virus. Clin Infect Dis, 2009; 49(11):1743–8.
25. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynam-ics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020; 382(13):1199–207.
26. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features ofpatients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223):497–506.
27. Bauch C, Oraby T. Assessing the pandemic potential of MERS-CoV. Lance, t2013; 382(9893):662–4.
28. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, et al. Trans-mission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science, 2003; 300(5627):1961–6
29. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science, 2009; 326(5953):729–33.
30. Sookaromdee P, Wiwanitkit V. Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: mathematical modelling of the outbreak.Asian Pac J Trop Med, 2020; 13(3):139–40.
31. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med, 2020; 382(14):1370–1.
32. Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med, 2004; 10(12):S88–97.
33. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl JMed, 2012; 367(19):1814–20.
34. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals insouthern China. Science, 2003; 302(5643):276–8.
35. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio, 2014;5(2), e00884-00814.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.